CNR1 and Parkinson disease: The authors of the article support the notion that CB1 activation reduces excitotoxicity and promotes neural regeneration, suggesting a possible neuroprotective role in PD based on animal models and cell cultures studies (Wang et al., 2022), however, there are no clinical studies on patients with PD confirming that notion.